Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs

Hypertension

Volumn 57, Issue 2, 2011, Pages 323-329

  Kopf, Phillip G ^a   Gauthier, Kathryn M ^a   Zhang, David X ^a   Falck, John R ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

adrenal cortex; angiotensin II; epoxyeicosatrienoic acid; hyperpolarizing factor; potassium channel

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ARACHIDONIC ACID DERIVATIVE; CYTOCHROME P450; DIHYDROXYICOSATETRAENOIC ACID; EPOXYICOSATRIENOIC ACID; IBERIOTOXIN; UNCLASSIFIED DRUG;

ADRENAL BLOOD FLOW; ADRENAL CORTEX ARTERY; ALDOSTERONE RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTERY; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL TONE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME INHIBITION; FEMALE; KIDNEY CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR MECHANICS; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; STEROIDOGENESIS; ZONA GLOMERULOSA;

8,11,14-EICOSATRIENOIC ACID; ADRENAL GLANDS; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; ARACHIDONIC ACID; ARTERIES; CATTLE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXIDE HYDROLASES; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS; ZONA GLOMERULOSA;

EID: 79551496438     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.158311     Document Type: Article

References (41)

1. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10(suppl 12):S258-S265.
2. 2 receptors: regulation, signalling and function. Blood Press. 2003;12:70-88.
3. Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst. 2006;7:3-14.
4. Williams GH. Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail Rev. 2005;10:7-13.
5. Funder J. Mineralocorticoids and cardiac fibrosis: the decade in review. Clin Exp Pharmacol Physiol. 2001;28:1002-1006.
6. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4e-LEFT ventricular hypertrophy study. Circulation. 2003;108:1831-1838.
7. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: randomized aldactone evaluation study investigators. N Engl J Med. 1999;341:709-717.
8. Breslow MJ. Regulation of adrenal medullary and cortical blood flow. Am J Physiol. 1992;262:H1317-H1330.
9. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intra-adrenal interactions in the regulation of adrenocortical steroi-dogenesis. Endocr Rev. 1998;19:101-143.
10. Bassett JR, West SH. Vascularization of the adrenal cortex: its possible involvement in the regulation of steroid hormone release. Microsc Res Tech. 1997;36:546-557.
11. Vinson GP, Pudney JA, Whitehouse BJ. The mammalian adrenal circulation and the relationship between adrenal blood flow and steroido-genesis. J Endocrinol. 1985;105:285-294.
12. Jasper MS, McDermott P, Gann DS, Engeland WC. Measurement of blood flow to the adrenal capsule, cortex and medulla in dogs after hemorrhage by fluorescent microspheres. J Auton Nerv Syst. 1990;30:159-167.
13. Hanke CJ, Campbell WB. Endothelial cell nitric oxide inhibits aldoste-rone synthesis in zona glomerulosa cells: modulation by oxygen. Am J Physiol Endocrinol Metab. 2000;279:E846-E854.
14. Hanke CJ, O'Brien T, Pritchard KA Jr, Campbell WB. Inhibition of adrenal cell aldosterone synthesis by endogenous nitric oxide release. Hypertension. 2000;35:324-328.
15. Natarajan R, Lanting L, Bai W, Bravo EL, Nadler J. The role of nitric oxide in the regulation of aldosterone synthesis by adrenal glomerulosa cells. J Steroid Biochem Mol Biol. 1997;61:47-53.
16. Quinn SJ, Williams GH. Regulation of aldosterone secretion. Annu Rev Physiol. 1988;50:409-426.
17. Spat A, Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev. 2004;84:489-539.
18. Hinson JP, Vinson GP, Whitehouse BJ. The relationship between per-fusion medium flow rate and steroid secretion in the isolated perfused rat adrenal gland in situ. J Endocrinol. 1986;111:391-396.
19. Hinson JP, Vinson GP, Whitehouse BJ, Price GM. Effects of stimulation on steroid output and perfusion medium flow rate in the isolated perfused rat adrenal gland in situ. J Endocrinol. 1986;109:279-285.
20. Vinson GP, Hinson JP, Toth IE. The neuroendocrinology of the adrenal cortex. J Neuroendocrinol. 1994;6:235-246.
21. Zhang DX, Gauthier KM, Campbell WB. Characterization of vasoconstrictor responses in small bovine adrenal cortical arteries in vitro. Endocrinology. 2004;145:1571-1578.
22. Zhang DX, Gauthier KM, Falck JR, Siddam A, Campbell WB. Steroid-producing cells regulate arterial tone of adrenal cortical arteries. Endocrinology. 2007;148:3569-3576.
23. Rosolowsky LJ, Hanke CJ, Campbell WB. Adrenal capillary endothelial cells stimulate aldosterone release through a protein that is distinct from endothelin. Endocrinology. 1999;140:4411-4418.
24. Blair-West JR, Coghlan JP, Denton DA, Fei DT, Hardy KJ, Scoggins BA, Wright RD. A dose-response comparison of the actions of angiotensin II and angiotensin III in sheep. J Endocrinol. 1980;87:409-417.
25. Schuijt MP, de Vries R, Saxena PR, Jan Danser AH. Prostanoids, but not nitric oxide, counterregulate angiotensin II mediated vasoconstriction in vivo. Eur J Pharmacol. 2001;428:331-336.
26. Gauthier KM, Zhang DX, Edwards EM, Holmes B, Campbell WB. Angiotensin II dilates bovine adrenal cortical arterioles: role of endothe-lial nitric oxide. Endocrinology. 2005;146:3319-3324.
27. Gauthier KM, Zhang DX, Cui L, Nithipatikom K, Campbell WB. Angio-tensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide. Hypertension. 2008;52:150-155.
28. Rosolowsky LJ, Campbell WB. Endothelin enhances adrenocorticotropin- stimulated aldosterone release from cultured bovine adrenal cells. Endocrinology. 1990;126:1860-1866.
29. Hanke CJ, Drewett JG, Myers CR, Campbell WB. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect. Endocrinology. 1998;139:4053-4060.
30. Kopf PG, Zhang DX, Gauthier KM, Nithipatikom K, Yi XY, Falck JR, Campbell WB. Adrenic acid metabolites as endogenous endothelium-derived and zona glomerulosa-derived hyperpolarizing factors. Hypertension. 2010;55:547-554.
31. Nithipatikom K, Grall AJ, Holmes BB, Harder DR, Falck JR, Campbell WB. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome p450 metabolites of arachidonic acid. Anal Biochem. 2001;298:327-336.
32. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
33. Gauthier KM, Jagadeesh SG, Falck JR, Campbell WB. 14,15-epoxyeicosa-5(Z)- enoic-MSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries. Hypertension. 2003;42:555-561.
34. Campbell WB, Deeter C, Gauthier KM, Ingraham RH, Falck JR, Li PL. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. Am J Physiol Heart Circ Physiol. 2002; 282:H1656-H1664.
35. Lu T, Zhang DM, Wang XL, He T, Wang RX, Chai Q, Katusic ZS, Lee HC. Regulation of coronary arterial BK channels by caveolae-mediated angioten-sin II signaling in diabetes mellitus. Circ Res. 2010;106:1164-1173.
36. Lun S, Espiner EA, Hart DS. Adrenocortical metabolism of angiotensin in sheep with adrenal transplants. Am J Physiol. 1978;235:E525-E531.
37. Nishiyama A, Fujisawa Y, Fukui T, Rahman M, Kondo N, Ogawa Y, Fanzhu L, Guoxing Z, Kimura S, Abe Y. Role of nitric oxide in regional blood flow in angiotensin II-induced hypertensive rats. Hypertens Res. 2001;24:421-427.
38. Simmons JC, Freeman RH. L-Arginine analogues inhibit aldosterone secretion in rats. Am J Physiol. 1995;268:R1137-R1142.
39. Moore SA. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci. 2001;16:195-200; discussion 215-221.
40. Zhang DX, Gauthier KM, Campbell WB. Acetylcholine-induced relaxation and hyperpolarization in small bovine adrenal cortical arteries: role of cytochrome P450 metabolites. Endocrinology. 2004;145:4532-4539.
41. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318.